March 2016

How do patents impact patients?

Photo Credit: Lana Abramova

India has the highest burden of drug-resistant TB in the world with close to 1,00,000 suspected cases.  Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) are on the rise, and access to new antibiotics will play a key role in developing new TB regimens to address growing treatment needs and improve cure rates.

Just 2% of people with the severest cases of drug-resistant TB currently have access to new, more effective treatments that could save their lives

Geneva, 21 March 2016—Two years after two new drugs to treat tuberculosis—the first in over 50 years—were conditionally approved for use, only 2% of the 150,000 people who need them have been able to access them, according to Doctors Without Borders / Médecins Sans Frontières (MSF).